CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Sep. 30, 2022	Mar. 31, 2022
Current assets
Cash	$ 19,604,025	$ 17,072,419
Accounts receivable	114,849	127,965
Prepaid expenses and other current assets	784,638	956,623
Total current assets	20,503,512	18,157,007
Property and equipment, net	1,138,623	441,238
Right-of-use lease asset	1,282,328	696,698
Patents, net	1,925	2,200
Restricted cash	87,506	87,506
Deposits	33,305	33,305
Total assets	23,047,199	19,417,954
Current liabilities
Accounts payable	361,001	499,962
Due to related parties	177,527	155,742
Deferred revenue	574,245	344,547
Lease liability, current portion	247,144	126,905
Other current liabilities	741,529	696,893
Total current liabilities	2,101,446	1,824,049
Lease liability, less current portion	1,077,529	602,505
Total liabilities	3,178,975	2,426,554
Stockholders’ Equity
Common stock, par value $0.001 per share; 60,000,000 and 30,000,000 shares authorized as of September 30, 2022 and March 31, 2022, respectively; 22,946,232 and 15,419,163 shares issued and outstanding as of September 30, 2022 and March 31, 2022, respectively	22,948	15,421
Additional paid-in capital	156,887,555	147,446,868
Accumulated deficit	(137,042,279)	(130,329,181)
Total Aethlon Medical, Inc. stockholders’ equity before noncontrolling interests	19,868,224	17,133,108
Noncontrolling interests	0	(141,708)
Total stockholders’ equity	19,868,224	16,991,400
Total liabilities and stockholders’ equity	$ 23,047,199	$ 19,417,954